company background image
897 logo

Wai Yuen Tong Medicine Holdings SEHK:897 Stock Report

Last Price

HK$0.32

Market Cap

HK$360.0m

7D

8.5%

1Y

-17.9%

Updated

19 Jan, 2025

Data

Company Financials

Wai Yuen Tong Medicine Holdings Limited

SEHK:897 Stock Report

Market Cap: HK$360.0m

897 Stock Overview

An investment holding company, engages in production and sale of Chinese and western pharmaceuticals and health food products in Mainland China and Hong Kong. More details

897 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance1/6
Financial Health6/6
Dividends3/6

My Notes

Capture your thoughts, links and company narrative

Wai Yuen Tong Medicine Holdings Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Wai Yuen Tong Medicine Holdings
Historical stock prices
Current Share PriceHK$0.32
52 Week HighHK$0.46
52 Week LowHK$0.10
Beta0.39
1 Month Change50.94%
3 Month Change57.64%
1 Year Change-17.95%
3 Year Change10.34%
5 Year Change1.59%
Change since IPO-100.00%

Recent News & Updates

Wai Yuen Tong Medicine Holdings Limited (HKG:897) Stock Catapults 50% Though Its Price And Business Still Lag The Industry

Jan 06
Wai Yuen Tong Medicine Holdings Limited (HKG:897) Stock Catapults 50% Though Its Price And Business Still Lag The Industry

Wai Yuen Tong Medicine Holdings Limited's (HKG:897) Low P/S No Reason For Excitement

Nov 19
Wai Yuen Tong Medicine Holdings Limited's (HKG:897) Low P/S No Reason For Excitement

Recent updates

Wai Yuen Tong Medicine Holdings Limited (HKG:897) Stock Catapults 50% Though Its Price And Business Still Lag The Industry

Jan 06
Wai Yuen Tong Medicine Holdings Limited (HKG:897) Stock Catapults 50% Though Its Price And Business Still Lag The Industry

Wai Yuen Tong Medicine Holdings Limited's (HKG:897) Low P/S No Reason For Excitement

Nov 19
Wai Yuen Tong Medicine Holdings Limited's (HKG:897) Low P/S No Reason For Excitement

Wai Yuen Tong Medicine Holdings Limited's (HKG:897) Share Price Boosted 51% But Its Business Prospects Need A Lift Too

Jul 26
Wai Yuen Tong Medicine Holdings Limited's (HKG:897) Share Price Boosted 51% But Its Business Prospects Need A Lift Too

Investors Give Wai Yuen Tong Medicine Holdings Limited (HKG:897) Shares A 46% Hiding

Mar 11
Investors Give Wai Yuen Tong Medicine Holdings Limited (HKG:897) Shares A 46% Hiding

The Strong Earnings Posted By Wai Yuen Tong Medicine Holdings (HKG:897) Are A Good Indication Of The Strength Of The Business

Dec 28
The Strong Earnings Posted By Wai Yuen Tong Medicine Holdings (HKG:897) Are A Good Indication Of The Strength Of The Business

Is Wai Yuen Tong Medicine Holdings (HKG:897) A Risky Investment?

Jul 11
Is Wai Yuen Tong Medicine Holdings (HKG:897) A Risky Investment?

Wai Yuen Tong Medicine Holdings (HKG:897) Takes On Some Risk With Its Use Of Debt

Jul 05
Wai Yuen Tong Medicine Holdings (HKG:897) Takes On Some Risk With Its Use Of Debt

Is Wai Yuen Tong Medicine Holdings (HKG:897) A Risky Investment?

Mar 08
Is Wai Yuen Tong Medicine Holdings (HKG:897) A Risky Investment?

Increases to Wai Yuen Tong Medicine Holdings Limited's (HKG:897) CEO Compensation Might Cool off for now

Aug 18
Increases to Wai Yuen Tong Medicine Holdings Limited's (HKG:897) CEO Compensation Might Cool off for now

Health Check: How Prudently Does Wai Yuen Tong Medicine Holdings (HKG:897) Use Debt?

Mar 17
Health Check: How Prudently Does Wai Yuen Tong Medicine Holdings (HKG:897) Use Debt?

Wai Yuen Tong Medicine Holdings' (HKG:897) Shareholders Are Down 75% On Their Shares

Jan 22
Wai Yuen Tong Medicine Holdings' (HKG:897) Shareholders Are Down 75% On Their Shares

Health Check: How Prudently Does Wai Yuen Tong Medicine Holdings (HKG:897) Use Debt?

Dec 16
Health Check: How Prudently Does Wai Yuen Tong Medicine Holdings (HKG:897) Use Debt?

Shareholder Returns

897HK PharmaceuticalsHK Market
7D8.5%0.6%2.1%
1Y-17.9%-0.9%23.7%

Return vs Industry: 897 underperformed the Hong Kong Pharmaceuticals industry which returned -0.9% over the past year.

Return vs Market: 897 underperformed the Hong Kong Market which returned 23.7% over the past year.

Price Volatility

Is 897's price volatile compared to industry and market?
897 volatility
897 Average Weekly Movement10.1%
Pharmaceuticals Industry Average Movement5.1%
Market Average Movement6.5%
10% most volatile stocks in HK Market14.0%
10% least volatile stocks in HK Market3.0%

Stable Share Price: 897's share price has been volatile over the past 3 months compared to the Hong Kong market.

Volatility Over Time: 897's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.

About the Company

FoundedEmployeesCEOWebsite
1897817Ching Ho Tangwww.wyth.net

Wai Yuen Tong Medicine Holdings Limited, an investment holding company, engages in production and sale of Chinese and western pharmaceuticals and health food products in Mainland China and Hong Kong. The company manufactures, processes, and sells traditional Chinese medicines under the brand Wai Yuen Tong brand and western pharmaceutical and personal care products under the Madame Pearl’s and Pearl’s brands. It also invests in commercial and industrial premises for rental.

Wai Yuen Tong Medicine Holdings Limited Fundamentals Summary

How do Wai Yuen Tong Medicine Holdings's earnings and revenue compare to its market cap?
897 fundamental statistics
Market capHK$360.03m
Earnings (TTM)HK$2.07m
Revenue (TTM)HK$762.40m

173.8x

P/E Ratio

0.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
897 income statement (TTM)
RevenueHK$762.40m
Cost of RevenueHK$372.98m
Gross ProfitHK$389.42m
Other ExpensesHK$387.35m
EarningsHK$2.07m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.0018
Gross Margin51.08%
Net Profit Margin0.27%
Debt/Equity Ratio29.0%

How did 897 perform over the long term?

See historical performance and comparison

Dividends

9.4%

Current Dividend Yield

1,664%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/19 22:04
End of Day Share Price 2025/01/17 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Wai Yuen Tong Medicine Holdings Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution